This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Quaker Chemical (KWR) Stock Down 9.8% Since Q4 Earnings Miss
by Zacks Equity Research
Quaker Chemical's (KWR) results were hurt by a significant spike in raw material costs, supply-chain and logistics cost pressures and constrained demand in automotive in Q4.
Cabot (CBT) Upgraded to Strong Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Cabot (CBT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Univar's (UNVR) Earnings and Revenues Top Estimates in Q4
by Zacks Equity Research
Univar (UNVR) benefits from higher chemical prices, operational execution and market share gains in Q4.
Koppers' (KOP) Q4 Earnings Top Estimates, Revenues Miss
by Zacks Equity Research
Koppers (KOP) gains on significantly higher sales in its Carbon Materials and Chemicals segment in the fourth quarter.
Westlake's (WLK) Earnings & Revenues Top Estimates in Q4
by Zacks Equity Research
Westlake (WLK) benefits from the continued strength in the residential construction market and strong repair and remodeling markets in Q4.
Why Cabot (CBT) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Cabot (CBT) have what it takes? Let's find out.
Has Aperam (APEMY) Outpaced Other Basic Materials Stocks This Year?
by Zacks Equity Research
Here is how Aperam (APEMY) and Cabot (CBT) have performed compared to their sector so far this year.
Reliance Steel (RS) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Reliance Steel (RS) benefits from higher pricing and healthy underlying demand in many of its major end markets in Q4.
Albemarle's (ALB) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Albemarle (ALB) benefits from higher sales at its Lithium and Bromine business segments in Q4.
Linde (LIN) Q4 Earnings Beat on Higher Prices & Volumes
by Zacks Equity Research
Increased prices and volumes from electronics, energy and chemicals end markets primarily drove Linde's (LIN) Q4 earnings.
Cabot (CBT) is a Top Dividend Stock Right Now: Should You Buy?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Cabot (CBT) have what it takes? Let's find out.
Is Aperam (APEMY) Stock Outpacing Its Basic Materials Peers This Year?
by Zacks Equity Research
Here is how Aperam (APEMY) and Cabot (CBT) have performed compared to their sector so far this year.
Cabot (CBT) Beats on Q1 Earnings & Sales, Raises FY22 Guidance
by Zacks Equity Research
While Cabot (CBT) slips to a loss in fiscal Q1, its revenues increase year over year on the back of higher sales across its segments.
Cabot (CBT) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Cabot (CBT) delivered earnings and revenue surprises of 21.70% and 18.74%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Eastman Chemical (EMN) Lags Q4 Earnings Estimates
by Zacks Equity Research
Eastman Chemical (EMN) delivered earnings and revenue surprises of -4.23% and 11.10%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Cabot (CBT) Q1 Earnings Expected to Decline
by Zacks Equity Research
Cabot (CBT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cabot (CBT) Gains on Strong End-Market Demand, Acquisitions
by Zacks Equity Research
Cabot (CBT) benefits from a recovery in demand from the pandemic-led slowdown, its targeted growth initiatives and acquisitions.
Cabot (CBT) to Divest Purification Solutions Unit for $111M
by Zacks Equity Research
Cabot (CBT) announces the selling off of its Purification Solutions business to One Equity Partners to divert resources to areas that promise strong growth and innovation.
Cabot (CBT) to Acquire Tokai Carbon Black Plant in China
by Zacks Equity Research
Cabot (CBT) inks deal to take over Tokai Carbon in order to upgrade the existing technology and boost the capacity of carbon black as it seeks to cater to the demand surge in lithium-ion batteries.
Cabot's (CBT) Q4 Earnings Beat Estimates, Revenues Lag
by Zacks Equity Research
Cabot's (CBT) Q4 results benefit from higher volumes and strong pricing in the Reinforcement Material segment.
Cabot (CBT) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Cabot (CBT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is Cabot (CBT) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here's Why You Should Invest In Cabot (CBT) Stock Now
by Zacks Equity Research
Cabot (CBT) gains on a recovery in demand, its disciplined execution of operations and targeted growth initiatives.
Axalta (AXTA) to Display Coatings at the Novi Battery Show
by Zacks Equity Research
Axalta (AXTA) will also unveil its new Plascoat thermoplastic powder that prevents corrosion, dielectric, stone chip and fire in a single layer of coating.
Celanese (CE) Completes Senior Unsecured Notes Offering
by Zacks Equity Research
Celanese (CE) intends to use net proceeds from the issuance of the notes to finance the tender offer and for general corporate purposes.